+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cosmetic Surgery Market - Forecasts from 2022 to 2027

  • PDF Icon

    Report

  • 136 Pages
  • January 2023
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5716775

The cosmetic surgery market is anticipated to increase from US$35.585 billion in 2020 to US$58.569 billion in 2027 at a CAGR of 7.38%.

Cosmetic surgery is a type of medical operation that uses both surgical and non-surgical methods to improve looks. A person may have cosmetic surgery done to reduce, accentuate, lift, or enhance a physical portion. Over the years, the demand for cosmetic surgery has grown significantly, spurred by improvements in surgical techniques, rising affluence, accelerating urbanization, the cultural effects of globalization, and an increase in doctors with specialized training.

An Increase in Licensed Medical Spas to Draw Clientele for Cosmetic Procedures driving the growth of the market

An expansive and appealing aesthetic medicine industry is now operating worldwide as a result of the rise in the number of patients undergoing surgical and non-surgical cosmetic procedures. The number of medical spas that have FDA approval and licensing has greatly expanded as a result of this factor in many various countries. Intense pricing competition brought on by the proliferation of medical spas offering a wide range of services has driven down the price of cosmetic procedures even more.

Technology-advanced Products' Accessibility Will Increase Demand for Cosmetic Procedures Globally

Leading producers of goods and devices on the market noted the profitable expansion and are working to enhance their current market share. Due to the growing demand for advanced products with fewer side effects and post-surgical interventions, market players are focusing on R&D to introduce advanced products.

By Geography

Geographically, the cosmetic surgery market is segmented as North America, South America, Europe, Middle East and Africa, and Asia Pacific. The biggest market for cosmetic surgery is in the United States, followed by Europe. Asia Pacific is also anticipated to have the fastest regional market growth. The availability of skilled surgeons, rising healthcare costs, increased technology spillover from developed economies, and expanding awareness of surgery are all factors contributing to this growth.

Key Developments:

  • June 2022: The introduction of a significant rebranding was announced by Sinclair, a global aesthetics company with its headquarters in London and a fully owned subsidiary of Huadong Medicine Corporation Limited. The addition of carefully chosen complementary medicines has improved an already exceptional assortment of injectables with the least invasive procedures. The most recent and cutting-edge HA technology is introduced to the market by MaiLi. With Lanluma, physicians can employ an injectable collagen stimulant both on the face and the body, and the new EBD business provides a whole range of cutting-edge energy-based solutions. This constantly growing portfolio, the creation of educational programs through Sinclair College, and a developing global presence are all reflected in the new identity. The brand has undergone a transformation to become contemporary, lively, and premium while preserving its elegance.
  • Jan 2021: The Frax ProTM system has been made available by Candela, a well-known international manufacturer of medical aesthetic devices. The first platform offering dual-depth skin resurfacing with both Frax 1550TM and the cutting-edge Frax 1940TM applicators is the FDA-cleared, non-ablative fractional device. The two treatment techniques focus on various layers of the skin, encouraging the production of new collagen and revealing smoother, more radiant skin. The focal reach of the Frax 1940 handpiece extends to a depth of around 200 m and emits a laser beam with a wavelength of 1940 nm for a shallow, epidermal approach. According to histology studies, the Frax 1550 handpiece's 1550 nm wavelength penetrates up to 800 m deeper. Clinical studies show that the Frax 1550 and Frax 1940 handpieces have excellent rates of textural improvement and patient satisfaction.

Product Offerings:

  • truSculpt® flex: Cutera's truSculpt® flex is based on the original Multi-Directional Stimulation (MDS), a brand-new technique for direct muscle stimulation that offers secure and reliable outcomes. MDS employs a bioelectrical impulse that has been shown via studies to give targeted muscle stimulation for the best thigh, glute, and abdominal strengthening, firming and toning results. The abdomen, buttocks, and thigh regions of truSculpt flex are simultaneously stimulated by eight different muscle groups. More treatment space is covered by truSculpt flex than by any other body sculpting device. The exercise plans include interval training, strength training, and a conditioning routine. The truSculpt flex workout is much more intense than standard gym-based activities.
  • The Lumenis M22TM Modular Aesthetic Laser Multi-Application Platform: A modular multi-application platform called M22TM is used to treat and remove hair from more than 30 different skin diseases. M22TM, which is used by doctors all over the world, enables one to effectively treat a wide range of patients and conditions. It can combine four different technologies in a Modular System. With the M22TM Universal IPL and AOPT combined, advanced users have complete control and can easily customize the parameters for each patient and each condition. Lumenis also has a premium M22 version with the golden line design that offers the aesthetic medical sector precise, secure, and successful light and laser-based therapies.

Market Segmentation:

By Type

  • Surgical Procedures
  • Non-Surgical Procedures
  • Liposuction

By Body Part

  • Face and Head
  • Breast
  • Body and Extremities

By Geography

  • North America
  • USA
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
Frequently Asked Questions about the Global Cosmetic Surgery Market

What is the estimated value of the Global Cosmetic Surgery Market?

The Global Cosmetic Surgery Market was estimated to be valued at $35.59 billion in 2020.

What is the growth rate of the Global Cosmetic Surgery Market?

The growth rate of the Global Cosmetic Surgery Market is 7.3%, with an estimated value of $58.57 billion by 2027.

What is the forecasted size of the Global Cosmetic Surgery Market?

The Global Cosmetic Surgery Market is estimated to be worth $58.57 billion by 2027.

Who are the key companies in the Global Cosmetic Surgery Market?

Key companies in the Global Cosmetic Surgery Market include Candela Corporation, Allergan, Merz pharma, Mentor Worldwide LLC, Lumenis and Cutera.

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY
3.1. Research Highlights

4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. GLOBAL COSMETIC SURGERY MARKET ANALYSIS, BY TYPE
5.1. Introduction
5.2. Surgical Procedures
5.3. Non-Surgical Procedures
5.4. Liposuction

6. GLOBAL COSMETIC SURGERY MARKET ANALYSIS, BY BODY PART
6.1. Introduction
6.2. Face and Breast
6.3. Breast
6.4. Body and Extremities

7. GLOBAL COSMETIC SURGERY MARKET ANALYSIS, BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Israel
7.5.4. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. Japan
7.6.3. India
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others

8. COMPETITIVE INTELLIGENCE
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES
9.1. Candela Corporation
9.2. Allergan
9.3. Merz Pharma
9.4. Mentor Worldwide LLC
9.5. Lumenis
9.6. Sinclair Pharma
9.7. Cutera
*List is not exhaustive

Companies Mentioned

  • Candela Corporation
  • Allergan
  • Merz pharma
  • Mentor Worldwide LLC
  • Lumenis
  • Sinclair Pharma
  • Cutera